Armin Rashidi, MD, PhD

Dr. Armin Rashidi MD, PhD
Faculty Member

Armin Rashidi, MD, PhD

Associate Professor
Clinical Research Division, Fred Hutch

Mail Stop: D5-310

Dr. Armin Rashidi studies how the microbiome, the community of bacteria living in and on our bodies, influences patients’ outcomes after intensive therapy for blood cancers. Our health is intimately tied to the health of our microbiomes, and treatment regimens for blood cancers, which can include immune-suppressing chemotherapy and antibiotics to stave off infection, often disrupt these communities. This disruption, or dysbiosis, can open the door to life-threatening infections and influence treatment complications. Rashidi studies how the makeup of individual microbiomes influence how they respond to cancer treatments and how different blood cancer treatments alter the patients’ microbiomes. With these insights, Rashidi hopes to develop better strategies to prevent and treat dysbiosis and improve blood cancer treatment outcomes. 

Other Appointments & Affiliations

Associate Professor
Division of Hematology and Oncology, UW School of Medicine


Hematology and Medical Oncology Fellowship, Washington University in St. Louis, 2016

Internal Medicine Residency, Eastern Virginia Medical School, 2013

PhD, Biogerontology, Newcastle University, Newcastle upon Tyne, 2010

MD, Tehran University of Medical Sciences, 2006

Research Interests

Impact of microbiome on outcomes of intensive therapy in patients with hematologic malignancies

Find a Clinical Trial Led by Dr. Rashidi

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email or call 206.667.2210